Statement from Institute for Biodefense Research Executive Director Prof. James Giordano, PH.D on Intelligence Assessment of Havana Syndrome

Mar 3, 2023

IIt was with particular interest, and considerable consternation that I read the recently released Director of National Intelligence office’s report addressing anomalous health incidents (AHIs) of the kind referred to as contributing to the so-called “Havana Syndrome”.  In the main, it is my opinion that the conclusions offered by this report are inconsistent with over five years’ accumulated evidence and subject matter analyses as conducted by numerous individual and institutional experts.

To wit, 

  1. The report fails to recognize and acknowledge the existing scientific and technological readiness of devices and methods capable of emitting directable energies. This failure of acknowledgement disregards existing United States patents, technical reports, and publications in the peer-reviewed (scientific and technological) literature demonstrating progress, developments, and operationalizable utility (i.e.- dual-use viability) of engineered products/devices of these types. As well, the report does not address or acknowledge explicit reports and evidence of programs of research, development, testing and evaluation of directable energy technologies that have been engaged by both trans-Atlantic and trans-Pacific near peer competitor nations.

2) The report disregards accumulated scientific and forensic analyses of possible and probable cause, specifically for those AHIs of personnel working at the US Embassy in Havana. Such analyses explicitly addressed and ruled out other factors, such as environmental variables, gross exposure to industrial or ecological chemicals and/or toxins, the presence of pre- and/or co-existing medical (inclusive of psychiatric) conditions; and psycho- and sociogenic effects.

3) The report inaptly aggregates all reported cases of such AHIs, and does not distinguish between the specific findings relevant to those individuals originally affected in Havana, from subsequent reports. To categorically aggregate the original Havana  cases, those in a current evaluative/verification pipeline, and the overwhelming majority of subsequent (broad public) cases (which, as has been well noted, represent incidences of other probable cause, as noted above) is both technically erroneous and ethically problematic, as it is a misrepresentation of data, information, and evidence-based knowledge.

4)  In these ways, the report 

A) dismisses iterative analyses of both governmental and non-governmental experts in subject matter constituent and contributory to relevant aspects of these AHIs and the circumstances and capabilities contributory to their probable cause; and therefore  is inconsistent with the scientific, technological, and medical evidence gathered and assimilated to date,  antithetical to Department of Defense and Department of State perspectives, as well as Executive Branch position as regards the evaluation and care of the initial Havana cases, and those in the verification pipeline; and 

B) Disrespects those persons/patients affected by these AHIs, as well as those providers who have dedicated professional expertise, skill and time to their evaluation and care.

In sum, the report raises far more, and multi-dimensionally serious, questions than it answers; and may incur impediment of current momentum of US efforts (as established by the Biden Administration) to recognize, quantify, develop preparative approaches and sustain readiness for risks and threats posed by current readiness levels of radical leveling and emerging biotechnologies. 

In such ways, the report is a disservice to the original cohort of patients, the multidisciplinary investigative expertise and analyses as thus far conducted, and trustworthiness of public health, national security and defense writ-large.

James Giordano, PhD
Executive Director, Institute for Biodefense Research
Manassas, VA

Pellegrino Center Professor of Neurology and Biochemistry
Chief, Neuroethics Studies Program
Chair, Sub-program in Military Medical Ethics
Co-director, O’Neill-Pellegrino Project in Brain Science and Global Health Law and Policy
Georgetown University Medical Center
Washington, DC, USA